AnaptysBio Inc. (ANAB)
NASDAQ: ANAB
· Real-Time Price · USD
21.90
0.81 (3.84%)
At close: Sep 05, 2025, 3:59 PM
21.90
0.00%
After-hours: Sep 05, 2025, 04:34 PM EDT
AnaptysBio Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 |
|---|---|---|
| Research and Development Segment Revenue | 22.26M | 27.77M |
| Research and Development Segment Revenue Growth | -19.83% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 10.15M | 14.13M | 10.19M | 10.56M | 8.85M | 11.9M | 10.28M | 10.17M | 10.68M | 10.82M | 9.41M | 8.86M | 8.17M | 10.2M | 5.39M | 5.43M | 5.25M | 5.42M | 5.09M | 4.79M | 4.69M | 4.29M | 3.83M | 3.81M | 4.31M | 4.14M | 3.74M | 4M | 3.83M | 3.95M | 2.54M | 2.39M | 2.35M | 2.05M | 912K | 1.01M | 1.15M | 1.22M | 1.07M | 889K | 944K | 682K |
| Selling, General, and Administrative Revenue Growth | -28.17% | +38.61% | -3.48% | +19.29% | -25.57% | +15.76% | +1.02% | -4.76% | -1.28% | +15.00% | +6.15% | +8.46% | -19.92% | +89.22% | -0.74% | +3.55% | -3.26% | +6.58% | +6.13% | +2.28% | +9.38% | +11.82% | +0.47% | -11.45% | +4.01% | +10.63% | -6.52% | +4.49% | -2.91% | +55.09% | +6.49% | +1.70% | +14.47% | +125.11% | -9.43% | -12.59% | -5.50% | +13.50% | +20.81% | -5.83% | +38.42% | n/a |
| Research and Development Revenue | 37.68M | 41.18M | 42.59M | 42.21M | 41.84M | 36.88M | 33.52M | 30.88M | 32.92M | 34.96M | 23.37M | 22.06M | 20.84M | 22.52M | 26.78M | 22.22M | 25.31M | 24.18M | 21.57M | 19.54M | 17.95M | 20.97M | 21.43M | 29.93M | 27.35M | 20.63M | 15.92M | 17.88M | 10.58M | 11.81M | 7.61M | 6.7M | 7.21M | 7.93M | 5.02M | 3.28M | 2.33M | 4.79M | 6.57M | 4.34M | 3.33M | 3.06M |
| Research and Development Revenue Growth | -8.49% | -3.31% | +0.89% | +0.88% | +13.46% | +10.00% | +8.57% | -6.21% | -5.82% | +49.56% | +5.94% | +5.85% | -7.43% | -15.91% | +20.50% | -12.22% | +4.67% | +12.14% | +10.36% | +8.88% | -14.40% | -2.14% | -28.42% | +9.44% | +32.57% | +29.59% | -10.98% | +68.98% | -10.39% | +55.27% | +13.57% | -7.05% | -9.20% | +58.19% | +52.83% | +40.56% | -51.21% | -27.18% | +51.32% | +30.62% | +8.52% | n/a |